Lost password ?
Sonasid
Outlook still positive, but caution is required beyond 2022
- "We have factored into our 2022 estimated sales forecasts the favourable price effect induced by the pass-through of high input costs. However, we have adopted a more cautious stance on 2023-24 ..."
Executive summary
Conflicts of Interest
Pages 38
Language English
Publish on June 10, 2022
€ 500
VAT Exl.
You may also be interested by these reports :
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.